• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Tandem Diabetes Care

Taking the fight to COVID-19 – BD, DHL, Novant on delivering, shipping and administering the vaccine

December 18, 2020 By Tom Salemi

This week’s DeviceTalks Weekly podcast shares the stories of the professionals who are working to get the new COVID-19 vaccines into the hands – and arms – of the front-line fighters and people at greatest risk. Leading off, Elizabeth Woody, SVP of public affairs at BD, explains how the company is preparing for the increasing […]

Filed Under: Device Talks Podcasts, Featured, Health Technology, Robotics Tagged With: Abbott Laboratories, Avail Medsystems, BD, Boston Scientific, DHL Supply Chain, Explorer Surgical, Johnson and Johnson, Medtronic, Novant Health, Pfizer, Stryker, Tandem Diabetes Care

Canada approves Tandem Diabetes Caree’s advanced hybrid closed-loop insulin pump

November 23, 2020 By Chris Newmarker

Tandem Diabetes Care (NSDQ:TNDM) announced today that Health Canada has approved its t:slim X2 insulin pump with Control-IQ technology. The news comes nearly a year after the U.S. launch of the t:slim X2 with Control-IQ. Get the full story on our sister site Drug Delivery Business News. 

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations Tagged With: Health Canada, Tandem Diabetes Care

Tandem Diabetes slides after hours on mixed bag Q3

November 5, 2020 By Sean Whooley

Tandem Diabetes Care (NSDQ:TNDM) shares took a hit after hours today on third-quarter results that were mixed compared to the consensus forecast. The San Diego-based insulin delivery and diabetes technology company posted losses of -$9.4 million, or -15¢ per share, on sales of $123.6 million for the three months ended Sept. 30, 2020, for a bottom-line […]

Filed Under: Business/Financial News, Diabetes, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Tandem Diabetes Care

MedTech 100 roundup: Industry hits another mid-pandemic high

August 3, 2020 By Sean Whooley

Despite a minor regression week-over-week, the medtech industry’s stocks hit another milestone as the COVID-19 rebound remains in progress. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.01 points at the end of last week (July 31). Overall, medtech stocks saw a -0.3% increase from the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Research & Development, Wall Street Beat Tagged With: 3m, Baxter, Boston Scientific, coronavirus, COVID-19, Dexcom, GE Healthcare, GlaxoSmithKline plc, Hillrom, Hologic, MedTech 100 Index, Moderna, National Institutes of Health (NIH), Philips, Sanofi, Smith & Nephew, Stryker, Tandem Diabetes Care, Teleflex

Tandem Diabetes posts $27m Q2 loss, reinstates earlier guidance

July 30, 2020 By Nancy Crotti

Tandem Diabetes Care (NSDQ:TNDM) posted Street-beating second-quarter sales and missed badly on earnings, but reinstated its earlier full-year 2020 guidance. The San Diego-based company — maker of insulin pumps and other diabetes management devices — reported a loss of -$27.1 million or -0.45¢ per share, on sales of $109.2 million for the three months ended June […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: Tandem Diabetes Care

Medtronic, Tandem Diabetes Care bury the hatchet on potential IP disputes

July 9, 2020 By Chris Newmarker

Two major insulin pump makers — Medtronic (NYSE:MDT) and Tandem Diabetes Care (NSDQ:TNDM) — announced today that they’ve inked a non-exclusive patent cross-license agreement related to diabetes treatment tech. The companies said the agreement will allow them to focus on innovation while avoiding the distraction of potential legal disagreements. The deal could be but another example of […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Featured, Legal News, Patent Infringement Tagged With: intellectual property, Medtronic, Tandem Diabetes Care, tandemdiabetes

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS